The Kyoto Encyclopedia of Genes and Genomes analysis revealed that PIK3-Akt, HIF-1, and longevity-regulating pathways were involved in the therapeutic role of the active ingredients in treating sarcopenia. The gene discussed is AKT1; the disease is sarcopenia.